PATHOLOGICAL BLOOD CHANGES IN SYSTEMIC LUPUS ERYTHEMATOSUS
Keywords:
systemic lupus erythematosus, anemia of chronic diseases, iron, hemoglobinAbstract
The article describes the features of the course of systemic lupus erythematosus in patients with anemia of chronic diseases, iron deficiency anemia and autoimmune hemolytic anemia. Patients from 18 to 60 years old with varying degrees of disease activity were examined. Various examination methods used to diagnose systemic lupus erythematosus as an autoimmune disease are reviewed, some of these methods include (complete blood count, serum iron, hematocrit, etc.). In addition, the pathological mechanism of anemic syndrome in systemic lupus erythematosus is discussed.
References
Alekseeva E.I., Dvoryakovskaya T.M., Nikishina I.P., Denisova R.V., Podchernyaeva N.S., Sukhorukikh O.A., Shubina L.S. Systemic lupus erythematosus: clinical guidelines. Part 1. Clinical guidelines.
Bugrova O.V., Uvarova E.A. To the question of the peculiarities of the pathogenesis of anemic syndrome in SLE.Zh. Vestnik OGU.2004(2). pp.138-143.
Iskanova G.Kh., Suleimanov A.S., Egamova S.Sh. Systemic vasculitis in children. J. Scientific discussion: questions of medicine, 2016. No. 12. P. 5-9.
Kuchma G. B., Bugrova O. V. Changes in the level of leukocytes of the leukocyte formula in patients with systemic lupus erythematosus depending on the course of the disease and the nature of the therapy. J. Vestnik VolGMU.2/34. 2010.S.100-103.
Petrov A.V., Beloglazov V.A., Shaduro D.V., Gaffarova A.R., Petrov A.A. Hematological manifestations of systemic lupus erythematosus in the early stage: association with other symptoms of the disease and possible prognostic significance. J. Scientific and practical rheumatology. 2019;57(2):166–170
Uvarova E. A. Features of anemic syndrome in patients with systemic lupus erythematosus. Abstract of diss.c.m.s. 2012.
Barr S, Zonana-Nacach A, Magder L, Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum.1999 Dec;42(12):2682-8. doi: 10.1002/1529-0131(199912)42:12<2682::AID-ANR26>3.0.CO;2-6.
Bastian H, Roseman J, Mcgwin G, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis, Lupus. 2002; 11(3): 152-60. doi: 10. 1191/ 0961203302 lu158oa.
Bernatsky S, Boivin J, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012 Feb;64(2):159-68. doi: 10.1002/acr.20683.
Faurschou M, Starklint H, Halberg P, Jacobsen S. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol. 2006 Aug;33(8):1563-9.
Karimdzhanov IA, Iskanova GH, Israilova NA, et al. Juvenile Idiopathic Arthritis: Etiopathogenesis. Therapy And Outcomes. Journal of Pharmaceutical Negative Results. 2022,13(8): 498-506. doi: 10.47750/pnr.2022.13.S08.65
Bruce I, Isenberg D, Wallace D, et al. Anti-C1q antibodies in systemic lupus erythematosus. Lupus. 2015 Jan;24(1):42-9. doi: 10.1177/0961203314547791. Epub 2014 Aug 14.
Hu W, Chen Y, Wang S, et al. Clinical. Morphological Features and Outcomes of Lupus Podocytopathy. Clin J Am Soc Nephrol.2016 Apr 7;11(4):585-92. doi: 10.2215/CJN.06720615. Epub 2016 Mar 16.
Petri M, Orbai A, Alarcon G, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 Aug;64(8):2677-86. doi: 10.1002/art.34473.
Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J. Rheumatol. February 2002; 29(2):288-91.
Gladman DD, Ginzler E, Goldsmith C, et al. The development and initial validationof the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996 Mar;39(3):363-9.doi:10.1002/art.1780390303.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
